Trials / Completed
CompletedNCT02260960
The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease
The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Physician Recommended Nutriceuticals · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that oral omega-3-acid triglyceride form will decrease dry-eye related symptoms as well as clinical markers associated with dry eye disease (TearOsmolarity, Schirmer-1 test values, corneal staining, and fluorescein tear break-up time) when compared to administration of placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Omega-3 (Triglyceride form) |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-10-09
- Last updated
- 2016-08-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02260960. Inclusion in this directory is not an endorsement.